-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E0JlMIgXeu9ZAPBSaydtYM7pP2n9MIbeaLrXzIXzUre5U0U7lfX9EywFZax//3OC I2e58vMQkS0Bh429TsdZzw== 0000912057-97-032624.txt : 19971006 0000912057-97-032624.hdr.sgml : 19971006 ACCESSION NUMBER: 0000912057-97-032624 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19971003 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: CIRCON CORP CENTRAL INDEX KEY: 0000719727 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 953079904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: SEC FILE NUMBER: 000-12025 FILM NUMBER: 97690744 BUSINESS ADDRESS: STREET 1: 6500 HOLLISTER AVE CITY: SANTA BARBARA STATE: CA ZIP: 93111 BUSINESS PHONE: 8059670404 DEFA14A 1 DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant / / Filed by a Party other than the Registrant /X/ Check the appropriate box: / / Preliminary Proxy Statement / / Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) / / Definitive Proxy Statement /X/ Definitive Additional Materials / / Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12 CIRCON CORPORATION - -------------------------------------------------------------------------------- (Name of Registrant as Specified In Its Charter) - -------------------------------------------------------------------------------- (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): /X/ No fee required. / / Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: ------------------------------------------------------------------------ (2) Aggregate number of securities to which transaction applies: ------------------------------------------------------------------------ (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): ------------------------------------------------------------------------ (4) Proposed maximum aggregate value of transaction: ------------------------------------------------------------------------ (5) Total fee paid: ------------------------------------------------------------------------ / / Fee paid previously with preliminary materials. / / Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: ------------------------------------------------------------------------ (2) Form, Schedule or Registration Statement No.: ------------------------------------------------------------------------ (3) Filing Party: ------------------------------------------------------------------------ (4) Date Filed: ------------------------------------------------------------------------ VOTE FOR CIRCON CIRCON FELLOW CIRCON SHAREHOLDERS: CIRCON'S SALES AND PROFITS ARE GROWING STRONGLY. Our strategic plan calls for the value of the Company to continue to grow and shareholders to be rewarded accordingly. U.S. Surgical (USSC) wants this value for themselves and THEY WANT TO PAY AS LITTLE AS POSSIBLE. They have spent MILLIONS of dollars to further their CAUSE. WHY? BECAUSE THEY EXPECT ENORMOUS PROFITS BY ACQUIRING CIRCON AT A BARGAIN PRICE! Our INDEPENDENT board members have carefully considered USSC's proposals. The Board's overwhelming conclusion: NOW IS THE WRONG TIME TO SELL DON'T VOTE FOR U.S. SURGICAL'S NOMINEES We think you will reach the same conclusion if you consider these three facts: 1. Current results show that the CIRCON STRATEGIC PLAN IS WORKING -- sales and profits are accelerating. Selling the Company now, deprives shareholders of the real value of an investment in Circon. 2. The hand-picked USSC NOMINEES ARE NOT INDEPENDENT -- USSC has given each of these nominees $100,000 in stock and agreed to indemnify them. YOU DON'T WANT THESE INDIVIDUALS NEGOTIATING WITH USSC ON YOUR BEHALF! 3. CIRCON'S BOARD MEMBERS, who own over 15% of the Company, have one objective -- MAXIMIZING THE VALUE OF YOUR CIRCON INVESTMENT FOR YOU, our shareholders. USSC's nominees have another objective -- forcing a quick sale of the Company as USSC has requested. DON'T LEAVE MONEY ON THE TABLE! TAKE THE ACTION THAT IS IN YOUR BEST INTEREST, NOT THE INTEREST OF USSC VOTE THE WHITE PROXY CARD FOR CIRCON Sincerely, /s/ RICHARD A. AUHLL ----------------------------- Richard A. Auhll President and Chairman of the Board Even if you have already voted the blue card, you can revoke your vote now by executing the WHITE card today or by simply calling our proxy solicitor D.F. King at (800) 628-8510. Ask for Ann Bekesh or John Cornwell. They can also answer any questions you may have regarding voting your proxy. -----END PRIVACY-ENHANCED MESSAGE-----